2025 in Review
2025 in Review: a year of innovation at Inlog
2025 in Review: a year of innovation at Inlog
In 2025, Inlog launched Inlog4Microbio, confirmed the market success of Inlog4Result and Inlog4Prescription, welcomed 41 new customers, and achieved two certifications. A year that strengthened our commitment to simplifying the daily work of healthcare institutions while supporting the quality of care.
New implementations and market success
This year, we further consolidated our position in the laboratory market:
- Inlog4Microbio: our paperless microbiology middleware, designed to streamline laboratory workflows and analysis processing.
- Inlog4Result and Inlog4Prescription: continued market success with growing adoption across laboratories.
- International expansion: our laboratory software suite continues to attract new markets worldwide.
Certifications and quality
2025 was also marked by key certifications obtained by our subsidiary Viskali-Ubilab, reinforcing the reliability of our solutions and the trust of our customers:
- ISO 9001
- Qualiopi
Innovation highlights
The major innovation of 2025 at Inlog was the transition of our software to web-based platforms, providing greater flexibility, accessibility, and ease of use for our clients.
Our objective remains clear: giving teams back valuable time so they can focus on what truly matters—quality patient care—while fully embracing digital technology.
Every success is the result of a collective effort, and we would like to thank our customers for their trust. Together, we continue to rethink and reshape medical IT.
Looking ahead to 2026, Inlog is already working on new innovations to support our customers in their digital transformation.
Stay tuned!
And you—which 2025 advancement had the greatest impact on your daily work? Share your experience in the comments!